Skip to content
Peptide Science Journal
Analytical Methods

How to Read a Peptide Certificate of Analysis (CoA): A Practical Guide for Researchers

A peptide Certificate of Analysis is the single document that distinguishes a reproducible research input from a black box. The CoA is the vendor’s claim about what is actually in the vial, supported by analytical data the vendor commissioned from a laboratory. Whether the CoA’s claim is true — whether the chromatogram is from this lot or last quarter’s, whether the mass spectrum is real or a stock image — is the question that separates a research-grade brand from a re-packager.

This guide is for researchers, lab managers, and informed buyers who want to read a peptide CoA the way an analytical chemist would: starting from the document’s structure, walking through HPLC purity, mass spectrometry confirmation, net peptide content, and the meta-data fields that establish lot traceability. By the end, you should be able to look at a CoA and answer three questions: Is this peptide what it says it is? Is it pure enough? And is this CoA from this lot?

The practical companion to this guide is a per-lot CoA verification system, where the lot number on the vial resolves to the published CoA in PDF form. Any research-supply vendor should offer one.

What is a Certificate of Analysis?

A Certificate of Analysis is an analytical report, issued by a manufacturer or contract laboratory, that documents the test results for a specific manufacturing lot of a chemical product. For peptides, the standard CoA documents:

  • Identification: the compound name, the lot number, the manufacturing date, the molecular formula, the molecular weight, and the amino acid sequence.
  • Purity: the result of a high-performance liquid chromatography (HPLC) analysis, typically reported as a percent area of the main peak relative to the total integrated area of all peaks above a baseline noise threshold.
  • Identity: the result of a mass spectrometry analysis confirming that the compound’s measured mass matches the theoretical mass calculated from the amino acid sequence.
  • Quantitative composition: the net peptide content (the actual mass of peptide in the vial, distinguished from the gross mass, which includes counterion salts and residual water).
  • Optional fields: moisture content (Karl Fischer titration), peptide content by UV absorbance, acetate or trifluoroacetate content, endotoxin levels, residual solvents.

A CoA may also include the analyst’s signature, the laboratory’s address, and the date the analysis was completed.

What a CoA is not: it is not a safety datasheet, it is not a stability statement, and it is not a release approval. The CoA documents what the lab found at the time the analysis was run. The vendor’s storage, shipping, and packaging are separate quality dimensions that the CoA does not certify.

The structure of a peptide CoA

A well-formed peptide CoA has five sections that you should be able to identify on any vendor’s document:

  1. Header / identification block — compound name, lot number, manufacturing date, CAS number, molecular formula, MW, sequence.
  2. HPLC analysis — purity result, method description, and the chromatogram itself.
  3. Mass spectrometry analysis — observed mass, theoretical mass, and the mass spectrum or mass-spectrum data table.
  4. Quantitative analysis — net peptide content and (where applicable) moisture, counterion content.
  5. Footer — analyst, signature, laboratory contact information, date.

If any of these is missing, the document is incomplete. The most common omissions in low-quality CoAs are: missing chromatogram (only the purity number), missing mass spectrum (only the observed mass number), and missing lot number (the document is generic, not lot-specific).

A CoA missing the lot number cannot be tied to the vial you hold. A CoA missing the chromatogram cannot be independently verified. Either is disqualifying.

Reading the HPLC chromatogram

HPLC — high-performance liquid chromatography — separates compounds in a mixture by passing them through a column where they interact with a stationary phase at different rates. For peptides, the standard method is reverse-phase HPLC with a UV detector at ~214 nm (peptide bond absorbance) or ~220 nm. The output is a chromatogram: a plot of detector response (y-axis) against time (x-axis).

The main peak corresponds to the target peptide. Smaller peaks correspond to impurities. Purity is calculated as:

Purity (%) = (Area of main peak / Total area of all peaks) × 100

A research-grade peptide CoA reports HPLC purity ≥ 99.0% for most compounds. Some compounds with intrinsic synthesis-route challenges (very long sequences, multiple disulfide bonds) may be reported at slightly lower purity; in those cases, the CoA should note the synthesis route and the source of the impurities.

When reading an HPLC chromatogram, look at:

  • The main peak. It should be a sharp, well-resolved peak that the integrator has correctly identified as the largest peak. A broad, tailing peak suggests sample issues, column issues, or method problems.
  • Retention time. The time at which the target peptide elutes. For a given method, retention time is reproducible lot-to-lot; if a vendor’s BPC-157 lot elutes at 7.2 minutes in one lot and 9.4 minutes in the next, the method has changed or the sample has changed.
  • Minor peaks. Real synthesis produces real impurities — deletion sequences (missing one amino acid), truncated peptides, oxidized side chains. A clean CoA typically shows 1–3 minor peaks below the 1% threshold. A CoA showing no impurity peaks at all on an aggressive y-axis scale should be treated with skepticism; the absence of any impurity is the chromatogram of a stock image, not a real sample.
  • Baseline. A noisy or drifting baseline suggests instrument or method problems. A clean baseline with quantifiable noise is what a working chromatogram looks like.
  • Y-axis scale. Check whether the y-axis is auto-scaled. Some vendors will show only a small portion of the y-axis, making impurity peaks invisible. The chromatogram should show the full scale and identify minor peaks above ~0.1% area.
  • Method block. The chromatogram should be accompanied by a method block describing the column, the mobile-phase gradient, the flow rate, the injection volume, and the detector. A chromatogram without a method is a chromatogram without a context.

The standard industry purity range for research-grade peptides is 99.0%–99.7% by HPLC area. Anything below 98% should be questioned. Anything reported above 99.9% should also raise a flag — that level of purity is achievable but uncommon, and a CoA reporting “100%” purity is reporting an analytical impossibility.

Reading the mass spectrum

Where HPLC tells you how much of one peak is in the sample, mass spectrometry tells you what that peak is. The mass spectrometer measures the mass-to-charge ratio (m/z) of ionized molecules. For peptides, the standard ionization is electrospray ionization (ESI), and the observed ions are typically [M+H]⁺ (singly protonated), [M+2H]²⁺ (doubly protonated, common for peptides), and [M+Na]⁺ (sodium adduct).

The CoA reports the observed mass (or the m/z of the observed [M+H]⁺ ion) and the theoretical mass calculated from the amino acid sequence. A match within ±0.5 Da of theoretical is the standard acceptance criterion for low-resolution mass spectrometry. High-resolution instruments report to four decimal places and use a tighter window.

For BPC-157 (theoretical monoisotopic mass ≈ 1418.73 Da, theoretical average mass ≈ 1419.53 Da), a CoA reporting [M+H]⁺ at 1419.5 or 1420.5 is consistent with the expected average mass. For semaglutide (theoretical average mass ≈ 4113.58), the same logic applies at scale.

Things to look for on the mass spectrum:

  • The expected ion is the dominant peak. [M+H]⁺ for small peptides; [M+2H]²⁺ or higher charge states for larger peptides.
  • The observed mass matches theoretical within the method’s stated accuracy.
  • Isotope envelope is visible (for high-resolution data) and consistent with the expected charge state.
  • No large unexpected peaks. A small ion 16 Da above the expected [M+H]⁺ indicates an oxidized form (typically methionine or tryptophan); a small ion 18 Da below indicates a dehydrated form. These are real synthesis-related observations and are not disqualifying at trace levels. Large unexpected peaks are.

If the CoA reports only a number (“Mass: 1419.5 — passes”) without the spectrum itself, ask for the spectrum. The number alone is not verifiable.

Net peptide content vs. gross mass

This is the field most likely to be missing on a low-quality CoA and most often misunderstood.

A vial labeled “10 mg BPC-157” contains 10 mg of total mass. That total mass includes:

  • The peptide itself (the active material).
  • Counterion salts (typically trifluoroacetate or acetate, present from the final purification step).
  • Residual water (peptides are hygroscopic; even a freshly-lyophilized peptide will retain some moisture).

A research-grade CoA reports the net peptide content as a percent of the gross mass, often in the range of 80–95%. A 10-mg vial with 85% net peptide content actually contains 8.5 mg of peptide and 1.5 mg of counterion + water.

For a researcher calculating a working concentration after reconstitution, the net peptide content is the value to use, not the labeled gross mass. A CoA that omits net peptide content omits the data the researcher needs.

Acceptable counterions for research peptides are typically acetate (CH₃COO⁻) or trifluoroacetate (CF₃COO⁻, abbreviated TFA). The CoA should identify which counterion was used. TFA is the more common counterion from standard SPPS (solid-phase peptide synthesis) purification; acetate is preferred for cell-culture work because TFA can interfere with some cellular assays.

Identity meta-data: lot number, manufacturing date, sequence

The header block of a CoA carries the data that ties the document to the vial:

  • Lot number. This is the unique identifier for this manufacturing batch. The lot number on the CoA must match the lot number on the vial label. If they don’t, the CoA is not for that vial. This is the single most important verification step.
  • Manufacturing date. Establishes the timeline against which storage stability claims apply.
  • CAS number. The Chemical Abstracts Service registry number for the compound. Verifiable against PubChem, ChemSpider, and other public chemistry databases.
  • Molecular formula and weight. Verifiable against the amino acid sequence.
  • Amino acid sequence. The primary structural identity of the peptide. Cross-checkable against any published reference for the compound.

A research-grade CoA includes all five. A re-packager’s CoA may include only the compound name and a purity number.

The vendor’s role: lot traceability and public verification

A vendor’s role in CoA quality extends beyond the analytical document itself. The vendor is responsible for:

  1. Lot-specific CoAs. Each manufacturing lot gets its own CoA, with a unique lot number that ties the document to a specific batch of vials. A vendor that uses a single “representative” CoA across multiple lots is hiding lot-to-lot variability.
  2. Public CoA verification. The CoA should be accessible to the buyer before purchase, or — at minimum — accessible through a public lookup system after the vial is in hand. Hiding CoAs behind a “request from sales” workflow is a quality-control posture that does not match the marketing posture.
  3. Lot-to-storage-to-shipping traceability. The vendor should be able to answer the question: “This vial has lot number X — when was it manufactured, where was it stored, when did it ship?” An RUO vendor that cannot answer that question is operating without the traceability that research requires.

publishes the CoA for every lot at the vendor’s verification portal. Each vial label carries a lot number; the lot number entered on the verify page returns the corresponding CoA PDF, with the chromatogram, the mass spectrum, the net peptide content, and the manufacturing date. The system is intentionally simple: type the lot, get the document. No login. No “contact sales.” No friction between the buyer and the data.

A simple checklist for evaluating a peptide CoA

If you have a CoA in hand, walk through this checklist before committing the compound to your design:

  1. Does the CoA have a lot number, and does it match the vial?
  2. Does it have a manufacturing date?
  3. Does the CAS number match the published CAS for the compound?
  4. Does the molecular formula match the amino acid sequence?
  5. Is the HPLC purity reported as ≥ 99.0%?
  6. Is the HPLC chromatogram itself included — with method, retention time, full y-axis scale, and visible minor peaks?
  7. Is the mass spectrum itself included, with observed mass within ±0.5 Da of theoretical (or tighter for high-resolution data)?
  8. Is the net peptide content reported, with counterion identified?
  9. Is the document signed by an analyst, with the laboratory’s name and address?
  10. Is the CoA accessible publicly through the vendor’s site, or does it require contacting sales?

A CoA that passes all ten checks is the kind of document a reproducible research design requires.

What if a CoA fails the checklist?

If a CoA is missing fields, the right response is to ask. A legitimate vendor will provide the missing data. A vendor that cannot or will not is a vendor whose CoA is not actually a CoA.

If the data conflict — purity reported below the labeled grade, mass outside the acceptance window, formula inconsistent with the sequence — the lot has a real problem and should not be used. A research-grade vendor will replace the lot.

If the CoA is from a different lot than the vial, the document does not apply to the material in hand. Either the wrong CoA was filed or the wrong vial was shipped. Resolve before use.

Beyond the CoA: what a CoA cannot tell you

A CoA documents the state of the lot at the time of analysis. It does not tell you:

  • How the lot was stored after analysis and before shipping.
  • How the lot was packaged.
  • Whether the lot was exposed to humidity or heat in transit.
  • Whether the vial seal was intact on arrival.

These dimensions of quality are the vendor’s responsibility, but they are not visible on the CoA. The buyer’s role is to inspect the vial on arrival: intact rubber septum, dry contents (no visible moisture), the labeled lot matches the CoA. If the vial is compromised on arrival, the CoA is irrelevant.

For storage protocols after the vial is in hand, see guide on Lyophilized vs. Reconstituted Peptides: A Storage Protocol Guide. For bacteriostatic water and reconstitution supplies, see the research supplies category.

Summary

A peptide CoA is the analytical record that ties a specific manufacturing lot to a documented state. A research-grade CoA includes the lot number, manufacturing date, CAS, formula, MW, sequence, HPLC chromatogram with method and visible minor peaks, mass spectrum with observed-vs-theoretical mass, and net peptide content with identified counterion. A CoA that is missing any of these is incomplete. A CoA that cannot be matched to the lot on the vial is not for that vial.

Verifying a CoA is a routine, ten-minute exercise. It should be the first step a researcher takes after a vial arrives. Vendors who make verification easy — by publishing lot-specific CoAs through a public lookup system — are vendors whose quality posture matches their marketing posture.

Selected sources

  1. “Peptide Purity Testing: HPLC and Mass Spectrometry Explained.” Analytical methodology overview. https://medium.com/@certapeptides/peptide-purity-testing-hplc-and-mass-spectrometry-explained-certapeptides-12a0f6007b6e
  2. “Peptide Purity Verification: HPLC and Mass Spectrometry Analytical Methodology.” Industry technical reference. https://aminofoundry.com/blog/peptide-purity
  3. “How Are Peptides Tested? HPLC, CoA & Purity Explained.” Methodology reference. https://peptideslabuk.com/how-peptides-are-tested/
  4. “Peptide Purity Analysis Service.” Method reference (Creative Proteomics). https://www.creative-proteomics.com/proteinseq/peptide-purity-analysis-service.htm
  5. Eur. Pharm. and USP-NF guidance documents on peptide identification by HPLC and mass spectrometry (general standards reference; consult the current edition for active compendial methods).

Research Use Only — Disclaimer

The research peptides discussed on this page are described for laboratory and research purposes only. They are intended exclusively for in vitro experimentation and for use in animal studies under appropriate institutional oversight. They are not drugs, dietary supplements, cosmetics, or food additives. They are not for human consumption, not for veterinary use in companion animals, and not for any therapeutic, diagnostic, preventive, or palliative purpose.They are not drugs, dietary supplements, cosmetics, or food additives. They are not for human consumption, not for veterinary use in companion animals, and not for any therapeutic, diagnostic, preventive, or palliative purpose.

Nothing on this page constitutes medical advice. No statement on this page should be interpreted as a recommendation, claim, or representation that any peptide compound is safe, effective, or appropriate for any use in humans. Researchers must comply with all applicable laws, institutional review requirements, and biosafety protocols.

Buyers must be at least 21 years of age and must agree to use products strictly for research purposes.